A microfluidic route to producing small (<10 µm) bubbles with a narrow size distribution and long-time (at least, up to one month) stability is reported. The bubbles are encapsulated with a protein-polysaccharide shell. The strategy includes the following events, occurring in sequence: (i) a microfluidic generation of bubbles from a mixture of CO(2) and a minute amount of gases with low solubility in water, in an aqueous solution of lysozyme and sodium alginate; (ii) the dissolution of CO(2) leading to the shrinkage of bubbles and a local increase in acidity of the medium; (iii) the deposition of lysozyme at the gas-water interface triggered by the local decrease in pH; (iv) the deposition of alginate onto the lysozyme shell, due to the electrostatically driven complexation of alginate with lysozyme.
No takes yet. Share an insight, caveat, or question.
Park et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: